ORAMED PHARMACEUTICALS INC. Quarterly Interest Expense in USD from Q3 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from Q3 2023 to Q1 2024.
  • Oramed Pharmaceuticals Inc. Interest Expense for the quarter ending March 31, 2024 was $592K.
Interest Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $592K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $826K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.